NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product D...( BEDMINSTER N.J. Oct. 9 /- NPS Pha...),Health
Navigation Links
NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
Date:10/9/2007
BEDMINSTER, N.J., Oct. 9 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that by mutual agreement it has ended its collaboration with AstraZeneca to discover and develop drugs targeting metabotropic glutamate receptors (mGluRs). AstraZeneca has agreed to pay NPS $30 million to acquire NPS's assets related to the companies' research collaboration to discover and develop the compounds. NPS intends to use the proceeds to support further development of its late-stage product pipeline.
The two companies have been collaborating since March 2001 to discover and develop compounds that are active at these receptors and have identified several drug candidates currently in preclinical and Phase 1 studies. Under the terms of the agreement, NPS will no longer provide research support for or maintain interests in any drugs discovered, developed and commercialized under this program.
Dr. Tony Coles, president and CEO of NPS, stated, "Monetizing our interests in the mGluR program at this time enables us to create greater near-term value for NPS shareholders. This strategic move creates investment flexibility for NPS and enables us to use the monies from this deal, the previously announced Nycomed GATTEX deal and the approximately $10 million in savings over the next two years from this transaction to support the further development of our late-stage pipeline products, PREOS and GATTEX, in specialty indications. We have had a very productive collaboration with AstraZeneca and wish them continued success with this program."
About NPS Pharmaceuticals
NPS discovers and develops small molecules and recombinant proteins as
drugs, primarily for the treatment of metabolic, bone and m
'/>"/>
| SOURCE NPS Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Heart disease in the newborn is related to maternal malnutrition
2. Individuals with sleep related breathing disorders more prone to heart disease
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Dampness related to asthma
6. Allergies are related to mothers menses
7. Genetic disorder related with sleep patterns
8. Energy intake directly related to portion size
9. Treatment for cholesterol-related illnesses likely with the discovery of receptor in mice
10. Age-Related Macular Degeneration - Risk Factors
11. New Drug Shows Significant Improvement In HIV-related Heart Condition
Post Your Comments:
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center...as , is one of a growing number of physicians who ... sites to connect with individuals who are interes...bid obesity. Dr. Kim is utilizing Facebook to shar...s practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free na...az and Yasmin birth control pills who have suffere..., Stroke, Heart Attack or other related cardiac is...all toll free at 1-800-856-6405 or go to the firm&...ill out an online case evaluation form. , ...
(Date:11/25/2009)...VILLE, Calif., Nov. 25 ... announced that the company will host two investor... December 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ...resentations surrounding carfilzomib in relapsed a...the 51st American Society of Hematology (ASH) Annu...
(Date:11/25/2009)...ACH, Calif., Nov. 25 Thanksgiving ...ebound seniors in the greater Long Beach area than...a program operated by Independence at Home (IAH), ...ears these organizations have gathered hundreds of...seniors in need in Long Beach, Lakewood, Signal Hi...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2[2] Pack Right for the Holidays to Avoid the ER[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills[0] Onyx Pharmaceuticals Announces December 2009 Investor Events[0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors
...as official insole for Mountain Running Team, AMH... as,the official insole of the 2008 Teva U.S. Moun...g supplier of open cell foam insoles in the,perfor...r support is integral,to the continued growth of o...
...on will provide greater access to members througho...ral areas, INDIANAPOLIS, Feb. 11 Anthem Blue Cro...ion of its Hoosier Healthwise network of,hospitals...re program., Under this new agreement, members wi...
...cancer drug Avastin (bevacizumab) is used to treat...erapy. This drug targets a protein called VEGF (va...blood vessel growth. Avastin inhibits the growth o... cause neurological side effects ranging from head...
...TER, Calif., Feb. 11 Nowadays, caring for,elderly... challenging.,Thankfully, some tools to ease the p... online services now being provided by FindCareHom...8,000,licensed homes, or State Licensed Residentia...
... PARK, N.J., Feb. 11 HLTH Corporation,(Nasdaq: H...le, for $575,million in cash, of its 48% minority ...lantic LLC and Hellman & Friedman LLC. General Atl...f HLTH, said: "HLTH is very,pleased to complete th...
...ington, DC When the public considers competing ar...d benefits, people will tend to agree with the exp...er what position the expert takes. The same will h...(PEN). The study was based on experiments involvin...
Other Medicine News:Health News:OrthoLite Joins the Teva U.S. Mountain Running Team 2Health News:Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members 2Health News:Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members 3Health News:FindCareHomes.com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home-Care 2Health News:HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million 2Health News:HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million 3Health News:Nanotechnology's future depends on who the public trusts 2OrthoLite Joins the Teva U.S. Mountain Running TeamAnthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise MembersAnti-cancer drug damages brain vesselsFindCareHomes.com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home-CareHLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 MillionNanotechnology's future depends on who the public trusts
(Date:11/25/2009)... , NEW YORK, Nov. 25 R...ch report is available in its catalogue: ,, P....reportlinker.com/p0164220/Pain-Management---Globa...neric drugs, emergence of pain management clinics,...pace of growth in the pain management market. Heal...
(Date:11/25/2009)... , DELFT, The Netherlands and JOHANNE...euticals, service division and Pyxis Discovery ann... agreement to jointly market both,companies, servi...chemistry and lead discovery expertise,will be cou...dicinal and,synthetic chemistry support to project...
(Date:11/25/2009)... , MOUNTAIN VIEW, Calif., Nov. 25 /PRNewswire...ase II/III clinical data from the Company,s PROTEC...ation in Crohn,s disease Trial) of Traficet-EN(TM)...ohn,s disease demonstrated clinical efficacy with ...study demonstrated evidence of clinical efficacy i...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Faculty of 1000 praised by Wellcome Trust 8954 1Prostate Cancer Translational Research in Europe meeting 3A Search for biomarkers continues 8949 1Prostate Cancer Translational Research in Europe meeting 3A Search for biomarkers continues 8949 2Prostate Cancer Translational Research in Europe meeting 3A Search for biomarkers continues 8949 3PTI Recycling Systems Formed to Sell Service Modular Food Grade rPET Production System Globally 49622 1PTI Recycling Systems Formed to Sell Service Modular Food Grade rPET Production System Globally 49622 2PTI Recycling Systems Formed to Sell Service Modular Food Grade rPET Production System Globally 49622 3[0] Reportlinker Adds Pain Management - Global Trends[0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering[0] ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference
...portant Factors Driving Nosocomial Pneumonia Presc...lts and ATS/IDSA Guidelines Arlington Medical Res... Hospital Anti-Infectives Insight Seri...Arlington,Medical Resources (AMR) and Decision Res...tal physicians estimate that if approved, Basilea/...
...L, Sept. 22 Enobia Pharma, a biotech company,focu...one disorders, today,announced key appointments to... Company,s senior management team in conjunction w...f ENB-0040 for the treatment of,hypophosphatasia.,...Vice President, Chief,Commercial Officer, and Jaya...
Other Medicine Technology:Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia 2Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvox's Patient Share in the Treatment of Nosocomial Pneumonia 3Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 2Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |